ISOSULFAN BLUE solution

Țară: Statele Unite ale Americii

Limbă: engleză

Sursă: NLM (National Library of Medicine)

Ingredient activ:

ISOSULFAN BLUE (UNII: 39N9K8S2A4) (ISOSULFAN BLUE - UNII:39N9K8S2A4)

Disponibil de la:

AnazaoHealth Corporation

INN (nume internaţional):

ISOSULFAN BLUE

Compoziție:

ISOSULFAN BLUE 10 mg in 1 mL

Calea de administrare:

SUBCUTANEOUS

Tip de prescriptie medicala:

PRESCRIPTION DRUG

Indicații terapeutice:

Isosulfan Blue 1% Injection delineates the lymphatic vessels following subcutaneous administration. It is an adjunct to lymphography (in primary and secondary lymphedema of the extremities; chyluria, chylous ascites or chylothorax; lymph node involvement by primary or secondary neoplasm; and lymph node response to therapeutic modalities) for visualization to the lymphatic system draining the region of injection Hypersensitivity to triphenylmethane or related compounds

Statutul autorizaţiei:

unapproved drug other

Caracteristicilor produsului

ISOSULFAN BLUE - ISOSULFAN BLUE SOLUTION
ANAZAOHEALTH CORPORATION
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
ISOSULFAN BLUE 1%
DESCRIPTION
Dear Medical Professional,
Per your order we have compounded Isosulfan Blue 1%. The
characteristics of this compounded
preparation are as follows:
CLINICAL PHARMACOLOGY
Isosulfan Blue has no known pharmacologic action. Following
subcutaneous administration, Isosulfan
blue 1% is selectively picked up by the lymphatic vessels. Thus, the
lymphatic vessels are delineated
by a bright blue color making them discernible from surrounding
tissue. There is some evidence that
50% of the isosulfan blue, from aqueous solution, is weakly bound to
serum protein (albumin). Since
interstitial protein is presumed to be carried almost exclusively by
lymphtics, and in view of evidence
of binding of dyes to proteins, visualization may be due to protein
binding phenomenon.
INDICATIONS AND USAGE
Isosulfan Blue 1% Injection delineates the lymphatic vessels following
subcutaneous administration. It
is an adjunct to lymphography (in primary and secondary lymphedema of
the extremities; chyluria,
chylous ascites or chylothorax; lymph node involvement by primary or
secondary neoplasm; and lymph
node response to therapeutic modalities) for visualization to the
lymphatic system draining the region of
injection
DOSAGE AND ADMINISTRATION
Isosulfan Blue 1% is to be administered subcutaneously, one-half (1/2)
ml into three (3) interdigital
spaces of each extremity per study. A maximum dose of 3 ml (30 mg)
isosulfan blue is injected.
CONTRAINDICATIONS
Hypersensitivity to triphenylmethane or related compounds
PRECAUTIONS
After subcutaneous administration of Isosulfan blue 1%, competent
personnel and emergency facilities
should be available for at least 30-60 minutes, since severe delayed
reactions have been known to
occur with similar compounds.
The admixture of